1. Home
  2. VECO vs HROW Comparison

VECO vs HROW Comparison

Compare VECO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veeco Instruments Inc.

VECO

Veeco Instruments Inc.

BUY

Current Price

$48.62

Market Cap

2.6B

Sector

Technology

ML Signal

BUY

HROW

Harrow Inc.

HOLD

Current Price

$33.08

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VECO
HROW
Founded
1945
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
1.7B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
VECO
HROW
Price
$48.62
$33.08
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$27.25
★ $69.86
AVG Volume (30 Days)
★ 496.7K
487.9K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.43
EPS
★ 0.18
N/A
Revenue
★ $664,294,000.00
N/A
Revenue This Year
$16.39
$31.62
Revenue Next Year
$12.40
$50.77
P/E Ratio
$252.50
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$26.00
$28.54
52 Week High
$86.63
$54.98

Technical Indicators

Market Signals
Indicator
VECO
HROW
Relative Strength Index (RSI) 58.82 33.82
Support Level $28.73 $32.46
Resistance Level $54.82 $36.37
Average True Range (ATR) 1.83 1.32
MACD 0.91 -0.12
Stochastic Oscillator 99.24 16.97

Price Performance

Historical Comparison
VECO
HROW

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: